Clinical Trial Update: FMT Capsules for rCDI [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating fecal microbiota transplant capsules for recurrent Clostridioides difficile infection, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• FMT Capsules (fecal microbiota transplant capsules)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Clostridioides Difficile Infection Recurrence, FMT | Phase 3 | Status: NOT_YET_RECRUITING